Follow on Google News News By Tag * Cancer Therapy * Cancer Treatment * Cancer Intervention * Pharmaceutcials * Ovarian Cancer * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | A Paper on ITE Inhibiting Human Ovarian Cancer Cell Proliferation and Migration Was PublishedAhR Pharmaceuticals Announces the Joint Publication of a Peer-reviewed Scientific Paper with a Science Team at University of Wisconsin-Madison
ITE is an endogenous ligand or natural hormone for the aryl hydrocarbon receptor. Once binding to the receptor, ITE activates and drives the hormone-receptor complex in mediating a series of important biological and pharmacological processes in the body. Evidences collected by scientists from AhR Pharmaceuticals and a global research community as well have demonstrated ITE’s potentials in treating cancer, obesity, and disorders related to imbalanced actions of immune systems. Leading the research efforts of AhR Pharmaceuticals’ For more information on AhR Pharmaceuticals, Inc., its technologies and research activities, please visit http://www.ahrpharma.com. For more information on University of Wisconsin-Madison, please visit http://www.wisc.edu. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|